US2009023895A1PendingUtilityA1
Hla-binding peptide, precursor thereof, and dna fragment and recombinant vector coding for said hla-binding peptide
Est. expiryFeb 7, 2026(expired)· nominal 20-yr term from priority
C12N 2760/16022A61K 38/08A61P 37/02A61K 39/145C12N 2760/16034A61K 39/12C07K 14/005C07K 7/06A61K 38/00A61P 37/04A61K 39/00
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An HLA-binding peptide binding to an HLA-A type molecule is provided that includes one or more types of amino acid sequence selected from the group consisting of SEQ ID NOS: 1 to 52, and not less than 8 and not more than 11 amino acid residues. All of these amino acid sequences are amino acid sequences predicted to bind to a human HLA-A molecule using a prediction program employing an active learning experiment method shown in FIG. 1.
Claims
exact text as granted — not AI-modified1 . An HLA-binding peptide binding to an HLA-A type molecule, said HLA-binding peptide comprising
one or more types of amino acid sequence selected from the group consisting of SEQ ID NOS: 1 to 52, and not less than 8 and not more than 11 amino acid residues.
2 . The HLA-binding peptide as set forth in claim 1 , comprising one or more types of amino acid sequence selected from the group consisting of SEQ ID NOS: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,11, 12,13, 14, 15, 16,17, 18, 21, 22, 23, 24, 25, 26, 27, 28, 30, 31, 34, 35, 36, 37, 38, 40, 41, 43, 45, 47, 48, 49, 50, 51, and 52.
3 . An HLA-binding peptide binding to an HLA-A type molecule, said HLA-binding peptide comprising
an amino acid sequence formed by deletion, substitution, or addition of one or two amino acid residues of said amino acid sequence contained in the HLA-binding peptide as set forth in claim 1 , and not less than 8 and not more than 11 amino acid residues.
4 . The HLA-binding peptide as set forth in claim 1 , wherein said HLA-binding peptide binds to a human HLA-A*2402 molecule.
5 . The HLA-binding peptide as set forth in claim 1 , wherein said HLA-binding peptide binds to a human HLA-A*0201 molecule.
6 . The HLA-binding peptide as set forth in claim 1 , wherein said HLA-binding peptide binds to a human HLA-A*0206 molecule.
7 . A DNA fragment comprising a DNA sequence coding for the HLA-binding peptide as set forth in claim 1 .
8 . A recombinant vector comprising a DNA sequence coding for the HLA-binding peptide as set forth in claim 1 .
9 . An HLA-binding peptide precursor changing within a mammalian body into the HLA-binding peptide as set forth in claim 1 .Join the waitlist — get patent alerts
Track US2009023895A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.